AR058679A1 - Preparacion farmaceutica que contiene meloxicam - Google Patents
Preparacion farmaceutica que contiene meloxicamInfo
- Publication number
- AR058679A1 AR058679A1 ARP060104300A ARP060104300A AR058679A1 AR 058679 A1 AR058679 A1 AR 058679A1 AR P060104300 A ARP060104300 A AR P060104300A AR P060104300 A ARP060104300 A AR P060104300A AR 058679 A1 AR058679 A1 AR 058679A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- solid formulations
- containing meloxicam
- meloxicam
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Abstract
Formulaciones solidas que comprenden como compuesto farmacéuticamente activo meloxicam y procedimientos para producir tales formulaciones solidas. Método para fabricar un medicamento para la prevencion y/o tratamiento de dolor, inflamacion, fiebre, mastitis aguda, diarrea, trastornos locomotores, cojera, osteoartritis, problemas de movilidad o afecciones respiratorias, en el que se usan las formulaciones solidas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05109064 | 2005-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058679A1 true AR058679A1 (es) | 2008-02-20 |
Family
ID=35512021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060104300A AR058679A1 (es) | 2005-09-30 | 2006-09-29 | Preparacion farmaceutica que contiene meloxicam |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070077296A1 (es) |
EP (1) | EP1942902A1 (es) |
JP (1) | JP2009510007A (es) |
KR (1) | KR20080059269A (es) |
CN (1) | CN101277701A (es) |
AR (1) | AR058679A1 (es) |
AU (1) | AU2006298895B9 (es) |
BR (1) | BRPI0617208A2 (es) |
CA (1) | CA2623201A1 (es) |
NZ (1) | NZ567627A (es) |
SG (1) | SG166115A1 (es) |
TW (1) | TW200727918A (es) |
WO (1) | WO2007039417A1 (es) |
ZA (1) | ZA200801275B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
WO2010085780A1 (en) * | 2009-01-26 | 2010-07-29 | Teva Pharmaceutical Industries Ltd. | Processes for coating a carrier with microparticles |
UY32427A (es) * | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
JP5685550B2 (ja) | 2009-02-13 | 2015-03-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Sglt2阻害剤、dpp−iv阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用 |
CN101618026B (zh) * | 2009-07-06 | 2011-03-16 | 江苏飞马药业有限公司 | 美洛昔康片及其生产工艺和用途 |
JP5758900B2 (ja) | 2009-09-30 | 2015-08-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルコピラノシル置換ベンジルベンゼン誘導体の調製方法 |
NZ598318A (en) | 2009-09-30 | 2014-02-28 | Boehringer Ingelheim Int | Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene |
US10610489B2 (en) | 2009-10-02 | 2020-04-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
CN102647971B (zh) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 用于包含美洛昔康的组合物的容器 |
AU2010347598B2 (en) | 2010-03-03 | 2014-11-27 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
UY33937A (es) | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina |
CN102525974A (zh) * | 2011-08-31 | 2012-07-04 | 南京仕必得生物技术有限公司 | 犬猫用美洛昔康片以及其制备方法 |
CN103099791A (zh) * | 2011-11-15 | 2013-05-15 | 海南澳美华制药有限公司 | 一种增加溶出度的美洛昔康的口服组合物 |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
US9192617B2 (en) | 2012-03-20 | 2015-11-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
CN103566819B (zh) * | 2012-08-07 | 2015-07-08 | 潮州市顺冠生物科技有限公司 | 一种加香剂造粒工艺及其造粒装置 |
US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
HUE041709T2 (hu) | 2013-04-05 | 2019-05-28 | Boehringer Ingelheim Int | Az empagliflozin terápiás alkalmazásai |
US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
CN113181161A (zh) | 2013-04-18 | 2021-07-30 | 勃林格殷格翰国际有限公司 | 药物组合物、治疗方法及其用途 |
US9526734B2 (en) * | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
CN106891419A (zh) * | 2017-04-12 | 2017-06-27 | 明光市国星凹土有限公司 | 一种凹凸棒的制作方法 |
WO2022097024A1 (en) * | 2020-11-06 | 2022-05-12 | Mylan Laboratories Ltd | Pharmaceutical composition comprising meloxicam |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2795529A (en) * | 1954-06-17 | 1957-06-11 | American Home Prod | Stabilized hyaluronidase solution containing calcium chloride |
US3288675A (en) * | 1964-03-20 | 1966-11-29 | Hoffmann La Roche | Parenteral sulfonamide compositions and processes |
BE789726A (fr) * | 1971-10-06 | 1973-04-05 | Merck & Co Inc | Suppositoires a l'indomethacine |
DE2756113A1 (de) * | 1977-12-16 | 1979-06-21 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
DE3217315C2 (de) * | 1982-05-08 | 1986-05-22 | Gödecke AG, 1000 Berlin | Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten |
DE3580140D1 (de) * | 1984-03-14 | 1990-11-22 | Jerome Corbiere | Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. |
DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
NL8600731A (nl) * | 1986-03-21 | 1987-10-16 | Dmv Campina Bv | Verbeterde gesproeidroogde lactose en werkwijze ter bereiding ervan. |
IT1216686B (it) * | 1988-04-01 | 1990-03-08 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione. |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
HU205550B (en) * | 1990-11-27 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pyroxycam solution of increased stability, free from effects damaging tussues |
ATE133068T1 (de) * | 1991-01-30 | 1996-02-15 | Wellcome Found | Wasserlösliche tabletten |
DE4217971C1 (de) * | 1992-05-30 | 1993-10-21 | Boehringer Ingelheim Vetmed | Verfahren und Wirbelbettapparatur zum Granulieren und/oder Umhüllen |
US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
JP2000500449A (ja) * | 1995-11-13 | 2000-01-18 | ピットミー・インターナショナル・ナムローゼ・フェンノートシャップ | 一酸化二窒素を含む鎮痛剤、抗炎症剤、および抗発熱剤のための投与媒体とそれらの医薬組成物 |
DE69711661T2 (de) * | 1996-06-20 | 2002-10-17 | Novartis Ag | Micrococcin antibiotika zur prävention und therapie der mastitis |
US6709678B2 (en) * | 1996-08-15 | 2004-03-23 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
NZ502990A (en) * | 1997-08-27 | 2002-02-01 | Hexal Ag | Pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
US6599529B1 (en) * | 1997-09-11 | 2003-07-29 | Nycomed Danmark A/S | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
EP0945134A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
CN1175904C (zh) * | 1998-05-15 | 2004-11-17 | 若素制药株式会社 | 抗炎滴眼剂 |
US6319519B2 (en) * | 1998-07-07 | 2001-11-20 | Norton Healthcare Ltd. | Anti-inflammatory pharmaceutical formulations |
DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
GB9823246D0 (en) * | 1998-10-24 | 1998-12-16 | Danbiosyst Uk | A nasal drug delivery composition |
US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
US6166012A (en) * | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
AU1548001A (en) * | 1999-11-24 | 2001-06-04 | Wakamoto Pharmaceutical Co., Ltd. | Ophthalmic aqueous preparation |
KR100446483B1 (ko) * | 2000-03-31 | 2004-09-01 | 미시간 스테이트 유니버시티 | 옥심 또는 이민으로부터 1,5-디데옥시-1,5-이미노 헥시톨제조방법 |
AU2001257511A1 (en) * | 2000-05-03 | 2001-11-12 | Joe D'silva | Process and device for producing liquid dosage formulations |
JP2004521856A (ja) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Cox−2選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物 |
WO2001089519A1 (en) * | 2000-05-22 | 2001-11-29 | Nitromed, Inc. | Thromboxane inhibitors, compositions and methods of use related applications |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
WO2002005799A2 (en) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
ES2223209B1 (es) * | 2001-12-11 | 2005-10-01 | Esteve Quimica, S.A. | Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion. |
US20040204413A1 (en) * | 2001-01-26 | 2004-10-14 | Joaquina Faour | Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant |
WO2002078625A2 (en) * | 2001-03-28 | 2002-10-10 | Pharmacia Corporation | Therapeutic combinations for cardiovascular and inflammatory indications |
US20020187187A1 (en) * | 2001-04-21 | 2002-12-12 | Toshimitsu Ohki | Fast disintegrating meloxicam tablet |
EP1250921A1 (en) * | 2001-04-21 | 2002-10-23 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Fast disintegrating meloxicam tablet |
US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
WO2003029411A2 (en) * | 2001-09-28 | 2003-04-10 | Brigham Young University | Novel cyclooxygenase variants and methods of use |
JP4042397B2 (ja) * | 2001-11-07 | 2008-02-06 | ひかり製菓株式会社 | 呈味改良剤 |
AU2002355012B2 (en) * | 2001-11-15 | 2008-05-15 | San-Ei Gen F.F.I., Inc. | Microcapsules and oral compositions containing the same |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20040001883A1 (en) * | 2002-03-30 | 2004-01-01 | Boehringer Ingelheim International Gmbh | Meloxicam suppositories |
US20040024042A1 (en) * | 2002-04-02 | 2004-02-05 | Vanderbilt University | COX2 inhibition in the prevention and treatment of autosomal dominant polycystic kidney disease |
DE10223013A1 (de) * | 2002-05-22 | 2003-12-04 | Boehringer Ingelheim Int | Verwendung von Meloxicam für die Linderung von Organverletzungen während Organoperation oder -transplantation |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
AU2003263599A1 (en) * | 2002-09-17 | 2004-04-08 | Nippon Boehringer Ingelheim Co., Ltd. | Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
US20040171611A1 (en) * | 2002-09-30 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline acetic acid solvate of meloxicam |
DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
CA2413705A1 (en) * | 2002-12-06 | 2004-06-06 | Raul Altman | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US20050197332A1 (en) * | 2002-12-10 | 2005-09-08 | Boehringer Ingelheim International | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
WO2004078113A2 (en) * | 2003-03-04 | 2004-09-16 | Pharmacia Corporation | Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20040198826A1 (en) * | 2003-04-07 | 2004-10-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis |
JP2004357506A (ja) * | 2003-05-30 | 2004-12-24 | Fancl Corp | ペット用サプリメント |
CN1816840A (zh) * | 2003-07-03 | 2006-08-09 | 皇家飞利浦电子股份有限公司 | 显示装置 |
US20050038018A1 (en) * | 2003-07-09 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Meloxicam compositions |
US20050147664A1 (en) * | 2003-11-13 | 2005-07-07 | Elan Pharma International Ltd. | Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery |
EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE102004025324A1 (de) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
WO2006100213A1 (en) * | 2005-03-23 | 2006-09-28 | Boehringer Ingelheim International Gmbh | Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
CN102647971B (zh) * | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 用于包含美洛昔康的组合物的容器 |
US9795568B2 (en) * | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
-
2006
- 2006-09-12 JP JP2008532712A patent/JP2009510007A/ja active Pending
- 2006-09-12 SG SG201007178-5A patent/SG166115A1/en unknown
- 2006-09-12 NZ NZ567627A patent/NZ567627A/en not_active IP Right Cessation
- 2006-09-12 BR BRPI0617208-3A patent/BRPI0617208A2/pt not_active IP Right Cessation
- 2006-09-12 WO PCT/EP2006/066262 patent/WO2007039417A1/en active Application Filing
- 2006-09-12 CA CA002623201A patent/CA2623201A1/en not_active Abandoned
- 2006-09-12 EP EP06793439A patent/EP1942902A1/en not_active Withdrawn
- 2006-09-12 KR KR1020087010324A patent/KR20080059269A/ko not_active Application Discontinuation
- 2006-09-12 CN CNA2006800363244A patent/CN101277701A/zh active Pending
- 2006-09-12 AU AU2006298895A patent/AU2006298895B9/en not_active Ceased
- 2006-09-19 US US11/532,952 patent/US20070077296A1/en not_active Abandoned
- 2006-09-29 AR ARP060104300A patent/AR058679A1/es unknown
- 2006-09-29 TW TW095136272A patent/TW200727918A/zh unknown
-
2008
- 2008-02-06 ZA ZA200801275A patent/ZA200801275B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20070077296A1 (en) | 2007-04-05 |
ZA200801275B (en) | 2008-12-31 |
SG166115A1 (en) | 2010-11-29 |
AU2006298895A1 (en) | 2007-04-12 |
KR20080059269A (ko) | 2008-06-26 |
AU2006298895B2 (en) | 2012-11-22 |
TW200727918A (en) | 2007-08-01 |
CN101277701A (zh) | 2008-10-01 |
EP1942902A1 (en) | 2008-07-16 |
BRPI0617208A2 (pt) | 2011-07-19 |
JP2009510007A (ja) | 2009-03-12 |
CA2623201A1 (en) | 2007-04-12 |
NZ567627A (en) | 2011-08-26 |
WO2007039417A1 (en) | 2007-04-12 |
AU2006298895B9 (en) | 2013-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058679A1 (es) | Preparacion farmaceutica que contiene meloxicam | |
AR109170A2 (es) | Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente | |
WO2008096775A1 (ja) | 疼痛疾患治療剤 | |
GT200800148A (es) | Agente terapéutico para la enfermedad inflamatoria intestinal conteniendo como ingrediente activo un derivado de 2-amino-1,3-propanediol o un método para el tratamiento de la enfermedad inflamatoria intestinal. | |
AR048705A1 (es) | Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
UY29377A1 (es) | Nuevas formilaciones líquidas de rotavirus, su preparación y sus usos. | |
WO2014205229A8 (en) | Use of high dose pridopidine for treating huntington's disease | |
CL2010001260A1 (es) | Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis. | |
NO20075136L (no) | Nye liposompreparater | |
ECSP066608A (es) | Suspensiones acuosas de ciclesonide para nebulización | |
BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
NO20076508L (no) | Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav | |
AR047993A1 (es) | Composicion farmaceutica que comprende pimobendano | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
AR057946A1 (es) | Formulacion de zonisamida de liberacion sostenidda | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
BRPI0617077A2 (pt) | Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
BRPI1010861A8 (pt) | métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica | |
UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
CR8912A (es) | Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la produccion de las mismas | |
CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
BRPI0606822A2 (pt) | composto, métodos para preparar um composto e para tratar dor e/ou inflamação, composição farmacêutica, e, manufatura de um medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |